Available IPD datapackage for study 'Phase 1, Multicenter, Open-label, Multiple-dose Study of DS-8201a to Assess the Effect on the QT Interval and Pharmacokinetics in Subjects With HER2-expressing Metastatic and/or Unresectable Breast Cancer'

This study will look at the effect of DS-8201a on heart rate and the movement of the drug
through the body (pharmacokinetics) in participants with a certain type of breast cancer
(HER2).

本研究将考察DS-8201a对HER2阳性乳腺癌受试者的心率以及药物体内过程（药代动力学，pharmacokinetics）的影响。